Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Book

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 6, 2022
Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcaponeJoseph P Schacht, Yeongbin Im, Michaela Hoffman, et al.
Lancet (London, England)|February 10, 1990
Use of urine for HIV-1 antibody screeningK J Reagan, C C Lile, G W Book, et al.
Journal of Substance Use|July 2, 2014
The potential utility of drinking motive questions to screen at-risk drinking in socially anxious patientsPeter M Miller, Sarah W Book, Suzanne Thomas, et al.
Alcoholism Treatment Quarterly|March 23, 2011
12-Step Therapy and Women with and without Social Phobia: A Study of the Effectiveness of 12-Step Therapy to Facilitate AA EngagementJ Scott Tonigan, Sarah W Book, Maria E Pagano, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2017
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking StatusJoseph P Schacht, Patrick K Randall, Patricia K Latham, et al.
Alcoholism, Clinical and Experimental Research|February 13, 2018
Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol DependenceRaymond F Anton, Patricia K Latham, Konstantin E Voronin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 15, 2017
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking StatusJoseph P Schacht, Patrick K Randall, Patricia K Latham, et al.
Biological Psychiatry Global Open Science|May 1, 2023
Medial Prefrontal Cortex Theta Burst Stimulation Improves Treatment Outcomes in Alcohol Use Disorder: A Double-Blind, Sham-Controlled Neuroimaging StudyDaniel M McCalley, Navneet Kaur, Julia P Wolf, et al.
The American Journal on Addictions|June 24, 2021
Sleep and substance use disorder treatment: A preliminary study of subjective and objective assessment of sleep during an intensive outpatient programAllison K Wilkerson, Richard O Simmons, Gregory L Sahlem, et al.
Alcoholism, Clinical and Experimental Research|August 11, 2020
Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical TrialRaymond F Anton, Konstantin E Voronin, Sarah W Book, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 6, 2022
Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcaponeJoseph P Schacht, Yeongbin Im, Michaela Hoffman, et al.
Lancet (London, England)|February 10, 1990
Use of urine for HIV-1 antibody screeningK J Reagan, C C Lile, G W Book, et al.
Journal of Substance Use|July 2, 2014
The potential utility of drinking motive questions to screen at-risk drinking in socially anxious patientsPeter M Miller, Sarah W Book, Suzanne Thomas, et al.
Alcoholism Treatment Quarterly|March 23, 2011
12-Step Therapy and Women with and without Social Phobia: A Study of the Effectiveness of 12-Step Therapy to Facilitate AA EngagementJ Scott Tonigan, Sarah W Book, Maria E Pagano, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 11, 2017
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking StatusJoseph P Schacht, Patrick K Randall, Patricia K Latham, et al.
Alcoholism, Clinical and Experimental Research|February 13, 2018
Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol DependenceRaymond F Anton, Patricia K Latham, Konstantin E Voronin, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 15, 2017
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking StatusJoseph P Schacht, Patrick K Randall, Patricia K Latham, et al.
Biological Psychiatry Global Open Science|May 1, 2023
Medial Prefrontal Cortex Theta Burst Stimulation Improves Treatment Outcomes in Alcohol Use Disorder: A Double-Blind, Sham-Controlled Neuroimaging StudyDaniel M McCalley, Navneet Kaur, Julia P Wolf, et al.
The American Journal on Addictions|June 24, 2021
Sleep and substance use disorder treatment: A preliminary study of subjective and objective assessment of sleep during an intensive outpatient programAllison K Wilkerson, Richard O Simmons, Gregory L Sahlem, et al.
Alcoholism, Clinical and Experimental Research|August 11, 2020
Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical TrialRaymond F Anton, Konstantin E Voronin, Sarah W Book, et al.
Pageof 5